5 Stocks Under Wall Street’s Radar : Facebook Inc (NASDAQ:FB), InvenSense, Inc. (NYSE:INVN), Akamai Technologies, Inc. (NASDAQ:AKAM), MV Oil Trust (NYSE:MVO), NephroGenex, Inc. (NASDAQ:NRX),

‘Anti- Facebook Inc (NASDAQ:FB)’ platform Ello attracts thousands. It has been dubbed the “anti-Facebook” network because of a pledge to carry no adverts or sell user data.Facebook Inc (NASDAQ:FB) belongs to Technology sector. Its net profit margin is 23.70% and weekly performance is 2.86%. On last trading day company shares ended up $79.00. Facebook Inc (NASDAQ:FB) distance from 50-day simple moving average (SMA50) is 5.54%.

InvenSense (NASDAQ:INVN) has been given an average rating of “Buy” by the fifteen ratings firms that are currently covering the stock, AnalystRatingsNetwork reports. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. InvenSense, Inc. (NYSE:INVN) shares decreased -4.32% in last trading session and ended the day at $19.07. INVN Gross Margin is 48.10% and its return on assets is 3.30%. InvenSense, Inc. (NYSE:INVN) quarterly performance is -15.95%.

Akamai Technologies, Inc. (NASDAQ:AKAM) announced availability of Cloudlets, extensions to Akamai solutions that are designed to speed time to market for developers and offload infrastructure demand, each providing a specific and useful functionality that is accessed via the Akamai Intelligent Platform . On 29 September, Akamai Technologies, Inc. (NASDAQ:AKAM) shares decreased -0.15% and was closed at $59.74. AKAM EPS growth in last 5 year was 15.30%. Akamai Technologies, Inc. (NASDAQ:AKAM) year to date (YTD) performance is 26.62%.

MV Oil Trust (NYSE:MVO) was downgraded by Zacks from an “outperform” rating to a “neutral” rating in a research note issued on Monday. They currently have a $30.70 price target on the stock. Zacks‘s price target indicates a potential upside of 11.14% from the company’s current price. MV Oil Trust (NYSE:MVO) ended the last trading day at $26.41. Company weekly volatility is calculated as 2.24% and price to cash ratio as 1518.57. MV Oil Trust (NYSE:MVO) showed a weekly performance of 3.98%.

On Sep 15, Newly public Raleigh drug developer NephroGenex, Inc. (NASDAQ:NRX) announced that it will grow roots in the Highwoods Office Park now that it signed a long-term deal for corporate headquarters there. NephroGenex, Inc. (NASDAQ:NRX) shares decreased -3.70% in last trading session and ended the day at $4.42. NRX return on assets is -80.00%. NephroGenex, Inc. (NASDAQ:NRX) quarterly performance is -27.30%.

Signup for free to be the first to receive exclusive free links. Now in your mailbox!
Join over 15,000 subscribers
Send me links

Your information will not be shared to anyone